Quadriceps myostatin expression in COPD

European Respiratory Journal

Volumn 36, Issue 3, 2010, Pages 686-689

  Man, W D C ^a   Natanek, S A ^a,b   Riddoch Contreras, J ^b   Lewis, A ^b   Marsh, G S ^a   Kemp, P R ^b   Polkey, M I ^a  

^a ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; MYOSTATIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; EXERCISE; EXERCISE TEST; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LETTER; LUNG FUNCTION TEST; MALE; MOUSE; MUSCLE ATROPHY; MUSCLE FATIGUE; MUSCLE MASS; MUSCULAR DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUADRICEPS FEMORIS MUSCLE; REAL TIME POLYMERASE CHAIN REACTION; SKELETAL MUSCLE;

AGED; CROSS-SECTIONAL STUDIES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MUSCULAR ATROPHY; MYOSTATIN; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUADRICEPS MUSCLE; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 77956602718     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00032510     Document Type: Letter

References (11)

1. Swallow EB, Reyes D, Hopkinson NS, et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007; 62: 115-120. (Pubitemid 46271716)
2. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-β superfamily member. Nature 1997; 387: 83-90.
3. Plant PJ, Brooks D, Faughnan M, et al. Cellular markers of muscle atrophy in chronic obstructive pulmonary disease (COPD). Am J Respir Cell Mol Biol 2009; 42: 461-471.
4. Swallow EB, Gosker HR, Ward KA, et al. A novel technique for nonvolitional assessment of quadriceps muscle endurance in humans. J Appl Physiol 2007; 103: 739-746.
5. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories, ATS statement: guidelines for the sixminute walk test. Am J Respir Crit Care Med 2002; 166: 111-117.
6. McPherron AC, Lee SJ. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci U S A 1997; 94: 12457-12461.
7. Carlson CJ, Booth FW, Gordon SE. Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading. Am J Physiol 1999; 277: R601-606.
8. Gilson H, Schakman O, Combaret L, et al. Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy. Endocrinology 2007; 148: 452-460. (Pubitemid 46021477)
9. Lewis MI, Fournier M, Storer TW, et al. Skeletal muscle adaptations to testosterone and resistance training in men with COPD. J Appl Physiol 2007; 103: 1299-1310. (Pubitemid 47605967)
10. Troosters T, Probst VS, Crul T, et al. Resistance Training Prevents Deterioration in Quadriceps Muscle Function During Acute Exacerbations of COPD. Am J Respir Crit Care Med 2010; 181: 1016-1017.
11. Wagner KR, Fleckenstein JL, Amato AA, et al. A phase I/II trial of MYO-029 in adult subjects with muscular dystrophy. Ann Neurol 2008; 63: 561-571.